Loomis Sayles Announces Senior Loan Portfolio Manager Retirement
Loomis, Sayles & Company, an affiliate of Natixis Investment Managers, announced today that Kevin Perry, portfolio manager on the senior loan team, will retire in March 2019 after 17 years with the company and 37 years in the industry. All senior loan portfolios will continue to be co-managed by portfolio managers John Bell and Michael Klawitter, who have been members of the team for 17 and 16 years, respectively. The team oversees approximately $10.7 billion1 in institutional and retail assets for global clients.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180918005187/en/
“Kevin has embodied Loomis Sayles’ values of collaboration, humility and prudent risk-taking every day since he and John joined us in 2001,” said Kevin Charleston, chief executive officer. “Kevin and John are considered pioneers in the bank loan market and their efforts have led to clients entrusting us with the management of more than $10 billion in bank loan assets. We are grateful for Kevin’s contributions to our firm, and to bank loan investing, and wish him the best in retirement.”
Until his retirement date, Kevin will continue in his leadership and portfolio management roles to ensure a seamless transition and provide continuity for clients. There will be no changes to the team’s style or investment philosophy.
“A hallmark of our senior loan team is that it is comprised of tenured investment professionals with deep expertise in the bank loan market, and we are confident in the team’s experience and ability to carry this legacy forward,” said Jae Park, chief investment officer. “Under John’s continued leadership, we believe the team is well-resourced and positioned for additional success.”
John joined Loomis Sayles in 2001, with Kevin Perry, to build the firm’s bank loan capabilities. John and Kevin were among the first non-bank buyers of bank loans and their work pre-dates the first bank loan index, which began in 1992. The team began managing bank loans in a conservative style, and later expanded to include several more flexible and structured products. Michael joined the team in 2002, became portfolio manager on a variety of strategies in 2016 and was named portfolio manager on the remaining products earlier this year.
The team will continue to receive considerable support from Cheryl Stober, who, as product manager, has extensive knowledge of the team’s portfolios and the bank loan market, and takes a very active role in client service, prospecting and marketing. Cheryl joined Loomis Sayles in 2005, and moved to the senior loan team as a portfolio analyst in 2007. She was promoted to product manager in 2013.
BIOGRAPHICAL INFORMATION: JOHN R. BELL
John Bell is a vice president of Loomis, Sayles & Company and portfolio manager for the Loomis Sayles fixed income group.
Previously, John was a vice president and portfolio manager at Back Bay Advisors, and was head of credit at Jurika & Voyles, where he helped manage fixed income assets, including high yield. He was also president and principal for Sextant Investments, a merchant bank, and director of research at Dabney/ Resnick, Inc., a brokerage specializing in distressed securities. John was one of the original non-bank buyers of bank loans starting in 1988, when he was in charge of developing the bank loan effort at First Capital Holdings/First Capital Life Insurance. He later became director of research at First Capital, which managed nearly $10 billion in assets, including over $4 billion of high yield bonds and over $300 million of bank loans.
John earned a BBA from the University of Massachusetts at Amherst and an MBA from the University of California, Berkeley.
John joined Loomis Sayles in 2001, with Kevin Perry, to build the firm’s bank loan capabilities. John and Kevin were among the first non-bank buyers of bank loans and their work pre-dates the first bank loan index, which began in 1992. The team began managing bank loans in a conservative style, and later expanded to include several more flexible and structured products.
BIOGRAPHICAL INFORMATION: MICHAEL L. KLAWITTER, CFA
Michael Klawitter is a vice president and portfolio manager for the senior loan team at Loomis, Sayles & Company.
Michael began his investment career in 1997 in fund operations at First Data where he managed a group of fund specialists before joining Loomis Sayles in 2000 as a senior specialist in the mutual fund group. After moving to the quantitative research and risk analysis (QRRA) group for two years, providing support to portfolio managers, traders and marketing professionals, Michael joined the senior loan team, where he analyzed credits and worked on special projects. He became a strategist in 2013 and was promoted to portfolio manager in 2016.
Michael earned a BA from the University at Buffalo and an MSF from Boston College.
BIOGRAPHICAL INFORMATION: CHERYL STOBER
Cheryl Stober is a vice president of Loomis, Sayles & Company and product manager for the senior loan team. She is responsible for communicating the benefits of the firm’s bank loan strategies to clients as well as internal and external partners. Cheryl researches various aspects of the bank loan market, from the effects of covenant lite to the dynamics of market participants. She also develops and curates content for marketing materials, and educates prospects and clients on the benefits of the asset class. Cheryl’s expertise lies in all things bank loan, including the firm’s products and the market in general.
Cheryl joined Loomis Sayles in 2005 as a senior operations analyst. In 2007, she joined the bank loan team as a portfolio analyst and was promoted to product analyst and product manager, respectively. Previously, Cheryl worked in bank loan operations at Bain Capital. Cheryl earned a BA in economics from Brandeis University and an MBA from Boston University.
ABOUT LOOMIS SAYLES
Since 1926, Loomis, Sayles & Company has helped fulfill the investment needs of institutional and mutual fund clients worldwide. The firm’s performance-driven investors integrate deep proprietary research and integrated risk analysis to make informed, judicious decisions. Teams of portfolio managers, strategists, research analysts and traders collaborate to assess market sectors and identify investment opportunities wherever they may lie, within traditional asset classes or among a range of alternative investments. Loomis Sayles has the resources, foresight and the flexibility to look far and wide for value in broad and narrow markets in its commitment to deliver attractive sustainable returns for clients. This rich tradition has earned Loomis Sayles the trust and respect of clients worldwide, for whom it manages $264.4 billion** in assets (as of June 30, 2018).
**Includes the assets of Loomis, Sayles & Co., LP, and Loomis Sayles Trust Company, LLC. Loomis Sayles Trust Company is a wholly owned subsidiary of Loomis, Sayles & Company, LP.
ABOUT NATIXIS INVESTMENT MANAGERS
Natixis Investment Managers serves financial professionals with more insightful ways to construct portfolios. Powered by the expertise of 26 specialized investment managers globally, we apply Active Thinking℠ to deliver proactive solutions that help clients pursue better outcomes in all markets. Natixis ranks among the world’s largest asset management firms¹ ($988.4 billion / €846.5 billion AUM²).
Natixis Investment Managers includes all of the investment management and distribution entities affiliated with Natixis Distribution, L.P. and Natixis Investment Managers S.A.
¹Cerulli Quantitative Update: Global Markets 2018 ranked Natixis
Investment Managers as the 16th largest asset manager in the world based
on assets under management as of December 31, 2017.
²Net asset value as of June 30, 2018. Assets under management (“AUM”), as reported, may include notional assets, assets serviced, gross assets and other types of non-regulatory AUM.
Natixis Distribution, L.P. (fund distributor, member FINRA | SIPC) and Loomis, Sayles & Company, L.P. are affiliated.
1 As of July 31, 2018.
Loomis, Sayles & Company
Orla O’Brien, 617-478-7480
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Grand Prize Winner in $1.75M Water Abundance XPRIZE Announced at XPRIZE Visioneering 201822.10.2018 17:49 | Pressemelding
During Visioneering 2018, XPRIZE’s annual gathering of philanthropists and innovators to evaluate concepts for future competitions, the Foundation revealed the results of its latest, completed XPRIZE. The Skysource / Skywater Alliance was announced as the grand prize winner of the $1.75M Water Abundance XPRIZE, a two-year competition aimed at alleviating the global water crisis with energy-efficient technologies that harvest fresh water from thin air. In addition at Visioneering, five new prize concepts were evaluated with top honors going to a prize concept called “Coral Survival”, a prize designed to protect and restore coral reefs. This prize will move forward into the XPRIZE pipeline. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181022005795/en/ The Skysource / Skywater Alliance team, based in Venice Beach, California, wins the Water Abundance XPRIZE (Photo: Business Wire) The Water Abundance XPRIZE, powered by the Tat
Positive Trial Results with Filgotinib in Psoriatic Arthritis and Ankylosing Spondylitis Both Published in The Lancet22.10.2018 17:15 | Pressemelding
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that detailed results from two clinical trials evaluating filgotinib, an investigational, selective JAK1 inhibitor, for the treatment of psoriatic arthritis and ankylosing spondylitis were both published in The Lancet. The publication of the Phase 2 EQUATOR data also coincides with a plenary session presentation at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting. “The results of the EQUATOR and TORTUGA studies demonstrate that filgotinib improved the signs and symptoms of patients with psoriatic arthritis whose disease had not responded to prior therapies and independently, for those with ankylosing spondylitis,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “These findings represent an important step forward in our efforts to improve outcomes for people livin
First Data Polska Deploys Inside Secure’s Mobile Payment Technology To Securely and Easily Connect to Mastercard and Visa22.10.2018 15:36 | Pressemelding
Regulatory News: Inside Secure (Paris:INSD) (Euronext Paris: INSD), at the heart of security solutions for mobile and connected devices, today announced that First Data Polska S.A., a division of the global leader in commerce-enabling technology, selected Inside Secure technology to enable secure and flexible connections to Mastercard and Visa. First Data Polska S.A. chose Inside Secure’s Mobile Payment Client to easily integrate their solution with the Visa Token Service (VTS) and Mastercard Digital Enablement Service (MDES) – today’s major tokenization services that convert sensitive data into unique tokens that allow mobile payments to be processed. “Security and reliability are continual requirements for our services,” said Jolanta Rycerz, Member of Management Board at First Data Polska S.A. “We see Inside Secure as a valuable technology provider that enables us to easily migrate to the latest mobile payment technology and security standards. Thanks to Inside Secure, our customers,
PMI Launches Search for Next President and CEO22.10.2018 14:00 | Pressemelding
Project Management Institute (PMI), the world’s leading professional membership organization for project managers, announced today that it has retained Heidrick & Struggles to help the organization find its next President and Chief Executive Officer (CEO). The dynamic leader shall oversee the implementation of a new strategic plan and guide the organization toward a future designed to help thousands of project professionals around the world accelerate their careers and make ideas a reality. Heidrick & Struggles is a premier provider of executive search, leadership assessment and development, organization and team effectiveness, and culture shaping services globally. PMI will conduct a comprehensive global review of both internal and external candidates for this key position. The selected candidate will embody PMI’s core values and possess the skillsets necessary to advance the organization’s key goals. PMI’s next President and CEO will help it execute a bold new multi-year initiative d
E2open to Acquire INTTRA, Adding the World’s Leading Ocean Shipping Network and Software Provider, Creating an Integrated Global Supply Chain and Logistics Operating Network22.10.2018 13:43 | Pressemelding
E2open, the one place in the cloud to run your supply chain, today announced the acquisition of INTTRA, the leading ocean shipping network, software and information provider. The combination of INTTRA’s ocean carrier and shipper network with E2open’s industry leading business network will create a unified global logistics and supply chain network. E2open and INTTRA will join efforts to strengthen the connections and streamline the information flow between manufacturers, suppliers, shipping service providers, ocean carriers and all the participants in global trade. E2open is the largest cloud-based provider of networked supply chain solutions, featuring a complete portfolio of applications that enable the world’s most complex supply chains to better plan, collaborate, and execute their end-to-end operations. More than 70,000 partner companies and 200,000 users, many of the biggest brands and manufacturers across a range of industries, use the E2open network and platform to orchestrate t
Patient-Data Platform Raremark Raises £3m to Enable Precision Medicine in Rare Disease22.10.2018 12:00 | Pressemelding
Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments. Raremark’s platform is the foundation for building research networks of rare disease patients and their families. Raremark provides biopharmaceutical companies with access to anonymized and aggregated patient data, helping to reduce the time and cost of clinical development. The Raremark platform engages and retains patients, leveraging machine-learning technologies in novel ways. The approach is designed to raise health literacy and informed participation in medical research, to improve the quality of existing therapies and t